Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2021

Stockholders' Equity Note [Abstract]

Schedule of stock option activity

(in thousands, except share and per share amounts)	Number of Shares			Weighted- average Exercise Price		Weighted- average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding at January 1, 2020		3,417,000		$	5.77		9.03		-
Options granted		40,000		$	10.38		-		-
Options exercised		-		$	-		-		-
Options cancelled		-		$	-		-		-
Outstanding at January 1, 2021		3,457,000		$	5.82		8.05		-
Options granted		823,000		$	20.63		10.0		-
Options exercised		(183,000	)	$	6.21		-		-
Options cancelled		-		$	-		-		-
Outstanding at December 31, 2021		4,097,000		$	8.67		7.21	$	14,414
Exercisable at December 31, 2021		2,743,760		$	6.45		6.91	$	10,890

Schedule of stock-based compensation expense

	Year Ended December 31, 2021		Year Ended December 31, 2020
Research and development	$	1,651,000	$	583,000
General and administrative		3,145,000		2,529,000
Total	$	4,796,000	$	3,112,000